BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

739 related articles for article (PubMed ID: 33058143)

  • 1. Deciphering the COVID-19 cytokine storm: Systematic review and meta-analysis.
    Mulchandani R; Lyngdoh T; Kakkar AK
    Eur J Clin Invest; 2021 Jan; 51(1):e13429. PubMed ID: 33058143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamics of cytokines and lymphocyte subsets associated with the poor prognosis of severe COVID-19.
    Li Q; Xu W; Li WX; Huang CL; Chen L
    Eur Rev Med Pharmacol Sci; 2020 Dec; 24(23):12536-12544. PubMed ID: 33336774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating Levels of Interleukin-6 and Interleukin-10, But Not Tumor Necrosis Factor-Alpha, as Potential Biomarkers of Severity and Mortality for COVID-19: Systematic Review with Meta-analysis.
    Udomsinprasert W; Jittikoon J; Sangroongruangsri S; Chaikledkaew U
    J Clin Immunol; 2021 Jan; 41(1):11-22. PubMed ID: 33128665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokine profiles in the detection of severe lung involvement in hospitalized patients with COVID-19: The IL-8/IL-32 axis.
    Bergantini L; d'Alessandro M; Cameli P; Otranto A; Luzzi S; Bianchi F; Bargagli E
    Cytokine; 2022 Mar; 151():155804. PubMed ID: 35063722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis of SARS-CoV-2 infection in the setting of the cytokine release syndrome.
    Azar MM; Shin JJ; Kang I; Landry M
    Expert Rev Mol Diagn; 2020 Nov; 20(11):1087-1097. PubMed ID: 32990479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic changes in lymphocyte subsets and parallel cytokine levels in patients with severe and critical COVID-19.
    Liu Y; Tan W; Chen H; Zhu Y; Wan L; Jiang K; Guo Y; Tang K; Xie C; Yi H; Kuang Y; Luo Y
    BMC Infect Dis; 2021 Jan; 21(1):79. PubMed ID: 33461503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and Immune Features of Hospitalized Pediatric Patients With Coronavirus Disease 2019 (COVID-19) in Wuhan, China.
    Wu H; Zhu H; Yuan C; Yao C; Luo W; Shen X; Wang J; Shao J; Xiang Y
    JAMA Netw Open; 2020 Jun; 3(6):e2010895. PubMed ID: 32492165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Parameters Representative of Immune Dysfunction in Patients with Severe and Fatal COVID-19 Infection: a Systematic Review and Meta-analysis.
    Qin R; He L; Yang Z; Jia N; Chen R; Xie J; Fu W; Chen H; Lin X; Huang R; Luo T; Liu Y; Yao S; Jiang M; Li J
    Clin Rev Allergy Immunol; 2023 Feb; 64(1):33-65. PubMed ID: 35040086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-6 and CD8+ T cell counts combined are an early predictor of in-hospital mortality of patients with COVID-19.
    Luo M; Liu J; Jiang W; Yue S; Liu H; Wei S
    JCI Insight; 2020 Jul; 5(13):. PubMed ID: 32544099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High Levels of Circulating IL-8 and Soluble IL-2R Are Associated With Prolonged Illness in Patients With Severe COVID-19.
    Ma A; Zhang L; Ye X; Chen J; Yu J; Zhuang L; Weng C; Petersen F; Wang Z; Yu X
    Front Immunol; 2021; 12():626235. PubMed ID: 33584733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations of immunological features with COVID-19 severity: a systematic review and meta-analysis.
    Zhang Z; Ai G; Chen L; Liu S; Gong C; Zhu X; Zhang C; Qin H; Hu J; Huang J
    BMC Infect Dis; 2021 Aug; 21(1):738. PubMed ID: 34344353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of cytokine profile and lymphocyte subsets in the severity of coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis.
    Akbari H; Tabrizi R; Lankarani KB; Aria H; Vakili S; Asadian F; Noroozi S; Keshavarz P; Faramarz S
    Life Sci; 2020 Oct; 258():118167. PubMed ID: 32735885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Longitudinal Immune Response to Coronavirus Disease 2019: Chasing the Cytokine Storm.
    Chau AS; Weber AG; Maria NI; Narain S; Liu A; Hajizadeh N; Malhotra P; Bloom O; Marder G; Kaplan B
    Arthritis Rheumatol; 2021 Jan; 73(1):23-35. PubMed ID: 32929876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Characteristics and Immune Injury Mechanisms in 71 Patients with COVID-19.
    Wu Y; Huang X; Sun J; Xie T; Lei Y; Muhammad J; Li X; Zeng X; Zhou F; Qin H; Shao L; Zhang Q
    mSphere; 2020 Jul; 5(4):. PubMed ID: 32669467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using IL-2R/lymphocytes for predicting the clinical progression of patients with COVID-19.
    Hou H; Zhang B; Huang H; Luo Y; Wu S; Tang G; Liu W; Mao L; Mao L; Wang F; Sun Z
    Clin Exp Immunol; 2020 Jul; 201(1):76-84. PubMed ID: 32365221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokine profile in plasma of severe COVID-19 does not differ from ARDS and sepsis.
    Wilson JG; Simpson LJ; Ferreira AM; Rustagi A; Roque J; Asuni A; Ranganath T; Grant PM; Subramanian A; Rosenberg-Hasson Y; Maecker HT; Holmes SP; Levitt JE; Blish CA; Rogers AJ
    JCI Insight; 2020 Sep; 5(17):. PubMed ID: 32706339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Helminth alleviates COVID-19-related cytokine storm in an IL-9-dependent way.
    Cao Z; Wang J; Liu X; Liu Y; Li F; Liu M; Chiu S; Jin X
    mBio; 2024 Jun; 15(6):e0090524. PubMed ID: 38727220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction and exhausted features of T lymphocytes under serological changes, and prognostic factors in COVID-19 progression.
    Mahmoodpoor A; Hosseini M; Soltani-Zangbar S; Sanaie S; Aghebati-Maleki L; Saghaleini SH; Ostadi Z; Hajivalili M; Bayatmakoo Z; Haji-Fatahaliha M; Babaloo Z; Farid SS; Heris JA; Roshangar L; Rikhtegar R; Kafil HS; Yousefi M
    Mol Immunol; 2021 Oct; 138():121-127. PubMed ID: 34392110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific cytokines in the inflammatory cytokine storm of patients with COVID-19-associated acute respiratory distress syndrome and extrapulmonary multiple-organ dysfunction.
    Wang J; Yang X; Li Y; Huang JA; Jiang J; Su N
    Virol J; 2021 Jun; 18(1):117. PubMed ID: 34088317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T cell counts and IL-6 concentration in blood of North African COVID-19 patients are two independent prognostic factors for severe disease and death.
    Belaid B; Lamara Mahammad L; Mihi B; Rahali SY; Djidjeli A; Larab Z; Berkani L; Berkane I; Sayah W; Merah F; Lazli NZ; Kheddouci L; Kadi A; Ouali M; Khellafi R; Mekideche D; Kheliouen A; Ayoub S; Hamidi RM; Derrar F; Gharnaout M; Allam I; Djidjik R
    J Leukoc Biol; 2022 Jan; 111(1):269-281. PubMed ID: 33527487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.